3-4

MSN Group is one of the fastest growing manufacturers of Active Pharmaceutical Ingredients (APIs) and Finished dosages in India. Established in the year 2003, MSN Group comprises of 330 API manufacturing plants (including one for Oncology), three finished dosage facility ( including one for Oncology)and a dedicated R&D Center . Our plants are ISO 9001-2000 certified, WHO: GMP, EU:GMP and USFDA approved. Our manufacturing units are designed to confirm to the principles of Quality, Safety and sound Environment.

Accuprcc Research Labs Pvt. Ltd. is the FDCA, NABL. ISO 9001:2015, GLP, CPCSEA, AYUSH and DSIR recognized Contract Research Organisation (C'RO) having Head Quarter at Ahmedabad, Gujarat and having branch offices at Sudbury, Canada and Pennsylvania, USA. Accuprcc is a service provider for various testing services required for pharmaceuticals, chemicals, phytochcniicals, herbal formulations, food and Medical devices.

CBCC Global Research, we are accelerating medical therapy development by providing high quality, affordable and innovative solutions.  We provide strategic solutions for all phases of clinical trials through efficient delivery of services for the flawless execution of projects, on time – every time.  We are committed to achieving excellence in all research projects by ensuring scientific validity, data integrity and compliance with the latest regulatory guidelines, thus striving to be a leading global clinical research organization (CRO).

Founded in 1849, Pfizer is the world's premier biopharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support

Post : Drug Regulatory Affairs

Lincoln Pharmaceuticals shares its presence with fellow foremost top notch excellence driven pharmaceutical producers, engaged in manufacturing and marketing several therapeutic molecules under WHO-GMP guidelines. What makes Lincoln stands apart is their commitment to deliver unsurpassed quality of innovative products for the betterment of human health. Our drugs are developed using best in class guidelines and all that at a very cost-effective rates.

OFFICER / EXECUTIVE
PRODUCT MANAGEMENT TEAM

Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India.  Intas' success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, Biotechnology and global operations over three decades.

Walk In Interview at INTAS PHARMACEUTICALS LTD for its Manufacturing Plant based in Ahmedabad (SEZ UNIT) as per below:

Caplin Steriles Limited, a subsidiary of fast growing pharmaceutical company Caplin Point Laboratories Ltd, was established in early 2019. The company has state of the art facilities to manufacture Sterile Injectable and Ophthalmic products.  Caplin Steriles places highest emphasis on Quality and Integrity in its products and businesses. The company continuously works on innovative technologies and products to ensure the safety and needs of the consumers are always met.

Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top six pharmaceutical companies in India. Through our sales and marketing headquarters in Baltimore, MD, Lupin Pharmaceuticals, Inc.

Unichem Laboratories Ltd Promoted by the late Mr. Amrut Mody, a pioneer of the Indian pharmaceuticals business, Unichem Laboratories has grown to become one of India's most respected pharmaceutical companies. It is committed to deliver better health through superior products. By combining strategic research and in-depth industry knowledge, Unichem aims to transform itself into a global pharmaceutical drug Company with an increasing focus on cutting-edge research and developed markets.